134 results
8-K
EX-99.1
ANIK
Anika Therapeutics Inc.
13 Mar 24
Anika Reports Fourth Quarter and Year-End 2023 Financial Results
4:10pm
a lot about the business, and are taking decisive action to further reduce spending and focus our strategy on driving the products that provide
8-K
EX-99.1
ANIK
Anika Therapeutics Inc.
2 Nov 23
Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business
4:11pm
, which underscore the strength of our strategy and the power of the growth engine we have created,” said Cheryl R. Blanchard, Ph.D., Anika’s President
8-K
EX-99.1
xxf8uft4hasg4n
21 Sep 23
Regulation FD Disclosure
7:55am
8-K
EX-10.1
f23xm zo7xoswiwiru
13 Apr 23
Anika Enters Into Cooperation Agreement with Caligan Partners
5:20pm
8-K
EX-99.1
qrwzpo5dua0jai9a6uu
13 Apr 23
Anika Enters Into Cooperation Agreement with Caligan Partners
5:20pm
PRRN14A
zy01lm7 icj0su4hbl86
6 Apr 23
Revised preliminary proxy statement filed by non-management
5:24pm
PRER14A
8sv9n1oagrzx1a
5 Apr 23
Preliminary revised proxy
11:19am
PREC14A
8rrnvrffksqh
30 Mar 23
Preliminary proxy with contested solicitation
5:12pm
DEFA14A
rxfvxun5 a3wooj
1 Jun 22
Additional proxy soliciting materials
12:08pm
DEFA14A
cpykxys7g
9 May 22
Additional proxy soliciting materials
4:00pm